Kryptos Biotechnologies Raises $10 Million in Series A Financing led by Osang Healthcare to Develop Kuick Molecular Diagnostics System
Amount Raised
$10 Million
Round Type
Series A
San FranciscoBiotechnologyHealth CareHealth DiagnosticsInvestors
Description
Kryptos Biotechnologies announced that they have raised $10 million in Series A financing led by Osang Healthcare to further develop Kryptos’s flagship point-of-care molecular diagnostics system KuickTM, which aims to advance the clinical study of respiratory combo tests and receive FDA approval by 2025, along with a strategic partnership for the manufacturing and distribution of its product.
Quick answer
Kryptos Biotechnologies raised $10 Million in a Series A round, dated April 4, 2024. Investors: Osang Healthcare. Kryptos Biotechnologies is based in San Francisco, California, United States.
- How much did Kryptos Biotechnologies raise?
- Kryptos Biotechnologies raised $10 Million in a Series A round on April 4, 2024.
- Who invested in Kryptos Biotechnologies?
- Osang Healthcare is named as investors in this round.
- What does Kryptos Biotechnologies do?
- Kryptos Biotechnologies, Inc. is a Life Science startup based in the Bay Area, California.
- Where is Kryptos Biotechnologies based and how big is it?
- Kryptos Biotechnologies is based in San Francisco, California, United States.
- Who are the decision-makers at Kryptos Biotechnologies?
- Fundz holds 1 contact at Kryptos Biotechnologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Health Diagnostics and Biotechnology around the same time
Companies in the same sectors as Kryptos Biotechnologies that raised within 45 days of this round, from Fundz verified event records.
- Cerenome, Inc. raised $18M (Post-IPO Equity) on May 6, 2024.
- Testmate Health raised $6M (Seed) on May 2, 2024.
- Karius® raised $100M (Series C) on May 2, 2024.
- Insight Molecular Diagnostics Inc. raised $16M on April 11, 2024.
- VolitionRx raised $100K (Pre-Seed) on March 12, 2024.
- bioAffinity Technologies raised $2.6M (Seed) on March 6, 2024.
Who to call at Kryptos Biotechnologies, and when
A new round usually means Kryptos Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kryptos Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kryptos Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kryptos Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kryptos Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKryptos Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.